Search

everythinglearnresearchcommunity

for

Search:↓

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Manage hair shedding by identifying triggers, possibly using supplements or medications, and tracking with a health calendar.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

The document concludes that using specific tools and tests is essential for identifying the cause of hair loss and deciding on the right treatment.

Pregnancy reduces anxiety in rats, but finasteride reverses this effect.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Activating ER-β, not ER-α, improves skin cell growth and wound healing.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

The first in-prison dermatology clinic in the U.S. faced challenges and found certain skin conditions common among inmates, with rare cases of serious skin cancer.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Ruby laser hair removal significantly reduces hair density.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Spironolactone effectively treats female pattern hair loss with few side effects.

Tamoxifen caused hair loss in a 52-year-old woman.